Development of rapid and point-of-care diagnostic kit for hepatitis c virus detection
Ended Definitive Contract Awarded Last action
- Contract number
- 75N93021C00047
- Awardee
-
Avantgen Inc. UEI WLNHKNPNT2M7
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $300,000
Award facts
- Opportunity
-
- A Solicitation of the National Institutes of Health (NIH) and The Centers for Disease Control and Prevention (CDC) for Small Business Innovation Research (SBIR) Contract Proprosals Pre-Solicitation · PHS20211 · Posted Jul 9, 2020
- A Solicitation of the National Institutes of Health (NIH) and The Centers for Disease Control and Prevention (CDC) for Small Business Innovation Research (SBIR) Contract Proprosals Solicitation · Posted Jul 28, 2020
- Contract value 100% obligated
- $300,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 22 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- San Diego, CA 92121, USA
- Research
- SBIR Program Phase I Action
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $300,000 |
About this award
This $300,000.00 Small Business Innovation Research (SBIR) Phase I contract was awarded by the Department of Health and Human Services' (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Avantgen Inc., a small biotechnology company based in San Diego, California. The contract is for the development of a rapid and point-of-care diagnostic kit for the detection of the hepatitis C virus. This award is part of NIAID's solicitation for innovative research to address public health needs, which included topics such as diagnostics, vaccines, and therapeutics for infectious diseases. Avantgen has previously been awarded other SBIR contracts from NIH and the National Cancer Institute for developing rapid tests, monoclonal antibodies, and other products, demonstrating its expertise in this area.
Quick answers
Who was awarded contract 75N93021C00047?
75N93021C00047 was awarded to Avantgen Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 27, 2021.
How much is contract 75N93021C00047 worth?
The government has obligated $300,000 on 75N93021C00047.
Was contract 75N93021C00047 competed?
The extent of competition for 75N93021C00047 was full and open competition after exclusion of sources. The government received 22 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award